Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy.

Berkeley RA, Steele LP, Mulder AA, van den Wollenberg DJM, Kottke TJ, Thompson J, Coffey M, Hoeben RC, Vile RG, Melcher A, Ilett EJ.

Cancer Immunol Res. 2018 Oct;6(10):1161-1173. doi: 10.1158/2326-6066.CIR-18-0309. Epub 2018 Sep 12.

PMID:
30209061
2.

Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene.

Kemp V, Dautzenberg IJC, Cramer SJ, Hoeben RC, van den Wollenberg DJM.

Gene Ther. 2018 Aug;25(5):331-344. doi: 10.1038/s41434-018-0032-9. Epub 2018 Jul 16.

PMID:
30013187
3.

Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.

Dautzenberg IJC, van den Hengel SK, de Vrij J, Ravesloot L, Cramer SJ, Hong SS, van den Wollenberg DJM, Boulanger P, Hoeben RC.

Sci Rep. 2017 Dec 15;7(1):17654. doi: 10.1038/s41598-017-17709-z.

4.

Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.

Kemp V, Dautzenberg IJC, Limpens RW, van den Wollenberg DJM, Hoeben RC.

Viruses. 2017 Sep 21;9(10). pii: E266. doi: 10.3390/v9100266.

5.

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus.

Kemp V, Hoeben RC, van den Wollenberg DJ.

Viruses. 2015 Dec 24;8(1). pii: E4. doi: 10.3390/v8010004. Review.

6.

Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.

van den Wollenberg DJ, Dautzenberg IJ, Ros W, Lipińska AD, van den Hengel SK, Hoeben RC.

Gene Ther. 2015 Mar;22(3):267-79. doi: 10.1038/gt.2014.126. Epub 2015 Jan 15.

PMID:
25588743
7.

Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A.

Dautzenberg IJ, van den Wollenberg DJ, van den Hengel SK, Limpens RW, Bárcena M, Koster AJ, Hoeben RC.

Gene Ther. 2014 Jun;21(6):609-17. doi: 10.1038/gt.2014.34. Epub 2014 Apr 17.

PMID:
24739522
8.

Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures.

van den Hengel SK, Balvers RK, Dautzenberg IJ, van den Wollenberg DJ, Kloezeman JJ, Lamfers ML, Sillivis-Smit PA, Hoeben RC.

Cancer Gene Ther. 2013 Sep;20(9):507-13. doi: 10.1038/cgt.2013.47. Epub 2013 Aug 2.

PMID:
23907517
9.

Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.

van den Wollenberg DJ, Dautzenberg IJ, van den Hengel SK, Cramer SJ, de Groot RJ, Hoeben RC.

PLoS One. 2012;7(10):e48064. doi: 10.1371/journal.pone.0048064. Epub 2012 Oct 24.

10.

Modification of mammalian reoviruses for use as oncolytic agents.

Van Den Wollenberg DJ, Van Den Hengel SK, Dautzenberg IJ, Kranenburg O, Hoeben RC.

Expert Opin Biol Ther. 2009 Dec;9(12):1509-20. doi: 10.1517/14712590903307370. Review.

PMID:
19916732
11.

A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.

van den Wollenberg DJ, van den Hengel SK, Dautzenberg IJ, Cramer SJ, Kranenburg O, Hoeben RC.

Gene Ther. 2008 Dec;15(24):1567-78. doi: 10.1038/gt.2008.118. Epub 2008 Jul 24.

PMID:
18650851
12.

Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.

van Houdt WJ, Smakman N, van den Wollenberg DJ, Emmink BL, Veenendaal LM, van Diest PJ, Hoeben RC, Borel Rinkes IH, Kranenburg O.

Cancer Gene Ther. 2008 May;15(5):284-92. doi: 10.1038/cgt.2008.2. Epub 2008 Feb 8.

PMID:
18259212
13.

KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.

Smakman N, van den Wollenberg DJ, Elias SG, Sasazuki T, Shirasawa S, Hoeben RC, Borel Rinkes IH, Kranenburg O.

Cancer Res. 2006 May 15;66(10):5403-8.

14.

Immunosuppression promotes reovirus therapy of colorectal liver metastases.

Smakman N, van der Bilt JD, van den Wollenberg DJ, Hoeben RC, Borel Rinkes IH, Kranenburg O.

Cancer Gene Ther. 2006 Aug;13(8):815-8. Epub 2006 Mar 10.

PMID:
16543920
15.

Relaxed template specificity in fowl adenovirus 1 DNA replication initiation.

Rademaker HJ, Fallaux FJ, Van den Wollenberg DJ, De Jong RN, Van der Vliet PC, Hoeben RC.

J Gen Virol. 2006 Mar;87(Pt 3):553-62.

PMID:
16476976
16.

Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.

Smakman N, van den Wollenberg DJ, Borel Rinkes IH, Hoeben RC, Kranenburg O.

J Virol. 2005 Dec;79(23):14981-5.

17.

The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability.

Vellinga J, van den Wollenberg DJ, van der Heijdt S, Rabelink MJ, Hoeben RC.

J Virol. 2005 Mar;79(5):3206-10.

18.

Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.

Vellinga J, Rabelink MJ, Cramer SJ, van den Wollenberg DJ, Van der Meulen H, Leppard KN, Fallaux FJ, Hoeben RC.

J Virol. 2004 Apr;78(7):3470-9.

19.

Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.

Ossevoort M, Visser BM, van den Wollenberg DJ, van der Voort EI, Offringa R, Melief CJ, Toes RE, Hoeben RC.

Gene Ther. 2003 Nov;10(24):2020-8.

PMID:
14566361
20.

Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.

Pietersen AM, van der Eb MM, Rademaker HJ, van den Wollenberg DJ, Rabelink MJ, Kuppen PJ, van Dierendonck JH, van Ormondt H, Masman D, van de Velde CJ, van der Eb AJ, Hoeben RC, Noteborn MH.

Gene Ther. 1999 May;6(5):882-92.

21.

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC.

Hum Gene Ther. 1998 Sep 1;9(13):1909-17.

PMID:
9741429
23.

Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region.

Hoeben RC, Fallaux FJ, Cramer SJ, van den Wollenberg DJ, van Ormondt H, Briët E, van der Eb AJ.

Blood. 1995 May 1;85(9):2447-54.

24.

Supplemental Content

Loading ...
Support Center